Navigation Links
New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
Date:3/14/2010

ATLANTA, March 14 /PRNewswire-FirstCall/ -- Late-breaking data presented today at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that Abbott's investigational MitraClip® system met both its primary safety and effectiveness endpoints(1), suggesting that the minimally invasive MitraClip procedure may be an important treatment option for patients with significant mitral regurgitation (MR). At one year, the MitraClip device demonstrated meaningful clinical benefits for patients with significant MR, including improvements in heart function, quality of life, and normal physical activity, and a decrease in cardiac symptoms. The EVEREST II trial is the first randomized trial of any minimally invasive mitral valve repair device compared to mitral valve surgery.

The MitraClip system includes a catheter-based device, which is delivered to the heart through a blood vessel in the leg (femoral vein). The MitraClip device is designed to reduce significant MR by clipping together the leaflets of the mitral valve (one of the four valves of the heart). MR is the most common type of heart valve insufficiency and occurs when the leaflets of the mitral valve do not close completely, causing blood to flow backwards and leak into the left atrium of the heart during the cardiac cycle. To maintain an adequate forward flow of blood throughout the body, the heart compensates by increasing the size of the left ventricle (main pumping chamber of the heart) to accommodate the increase in the volume of blood it is pumping.


'/>"/>
SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. New Study Demonstrates Safety of Balloon Sinuplasty(TM) Technology in Pediatric Patients Suffering From Chronic Sinusitis
2. Tobiras Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
3. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
4. AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs
5. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
6. Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer
7. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
8. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
9. Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies
10. Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection
11. European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... NORTH CHICAGO, Ill. , Feb. 26, 2015 ... announced that 15 abstracts of studies in its ... for presentation during the 67 th American ... Washington, D.C. , from April 18-25. The ... FDA-approved product, DUOPA, in addition to investigational treatments ...
(Date:2/26/2015)... , Feb. 26, 2015 Legislation passed ... a pharmacy provision to help prevent inappropriate prescriptions in ... Protecting the Integrity of Medicare Act (PIMA) of ... Chairman Kevin Brady (R-TX) and Ranking Member ... prescription drug abuse epidemic and implement the right policies, ...
(Date:2/26/2015)...  Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical ... Hepatitis B virus (HBV) and other viral infections, ... financing. Funds from this financing will accelerate the ... antiviral agent derived from Spring Bank,s ... into Phase II clinical trials for the treatment ...
Breaking Medicine Technology:AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
... 2011 The National Parkinson Foundation (NPF) ... announce their partnership to evaluate Kinetic,s Objective Parkinson,s Disease ... measuring the symptoms of Parkinson,s disease (PD).  The evaluation ... enrolled in NPF,s groundbreaking Quality Improvement Initiative (QII). ...
... Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce ... www.solosendoscopy.com on Friday July 1, 2011. The ... and new customers and includes comprehensive information for shareholders, ... streamlined navigation to allow for easy-to-use functionality, allowing users ...
Cached Medicine Technology:Kinetics Foundation and National Parkinson Foundation (NPF) Announce their Partnership to Evaluate Objective Parkinson's Disease Measurement System 2Kinetics Foundation and National Parkinson Foundation (NPF) Announce their Partnership to Evaluate Objective Parkinson's Disease Measurement System 3Solos Endoscopy, Inc. To Launch New Corporate Website 2
(Date:2/27/2015)... The V Foundation for Cancer Research, one ... excited to announce numerous promotions taking place this March. ... partnerships highlight The V Foundation’s significant work in the ... all to get involved. Awarding 100 percent of ... V Foundation has funded more than $130 million in ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 On February ... “The Real Liquid Botox ,” that details the development ... that is working its way through FDA trials. For those ... cream is very attractive. Of course, if the drug ... prescription at a physician’s office. (see: goo.gl/PQvQwk) , “As the ...
(Date:2/27/2015)... 27, 2015 The Dawn Greene Hospice, a ... Walsh Home (MMW) on the Upper East Side, was officially ... New York, His Eminence Timothy Michael Cardinal Dolan. , Thomas ... of Directors and a member of the ArchCare Board of ... William O’Brien, O.Carm, executive director of MMW, and Christina McInerney, ...
(Date:2/27/2015)... February 27, 2015 The UC Davis ... expertise have made it a beacon of hope for ... has been acknowledged by the national society committed to ... Huntington’s Disease Society of America — as a Level ... acknowledgement recognizes the center’s service to over 300 families ...
(Date:2/27/2015)... February 27, 2015 Insight Accelerator ... to advance the development of an in-line urine ... solution is being developed in direct response to ... 73% accuracy and error margins with potentially grave ... output measurement and provide trending data analysis to ...
Breaking Medicine News(10 mins):Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3Health News:Is Topical Botox the Next Big Thing? 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3
... Detroit - Opens Thursday, DETROIT, Jan. 14 On ... be opening a new School of Dentistry and,Clinic, part of ... of Detroit. The new wireless facility is one of the ... square feet, the School,s new location is more than twice,the ...
... voice.," (p. 31). Editor Jon,Meacham opens the cover package ... win in New Hampshire and whether the battle for,the ... the,historically complicated issues of race and gender. Meacham writes ... captures how many Americans, and,not just Democrats, already feel ...
... 12 "Without notMYkid, I,wouldn,t be here today," says ... parents didn,t know, as long as I was at ... me share my story,with kids today and prevent them ... is thrilled that a partnership between Chrysler LLC and,Barrett- ...
... Adolescents now Protected Against More Diseases than Ever ... ... 11 Updated immunization,recommendations for childhood influenza and adolescent meningococcal,vaccinations are ... by the Centers for Disease Control and,Prevention (CDC), the American Academy ...
... to End Breast Cancer at the 2008 Trumpet ... ... Komen,for the Cure and The Links, Incorporated, today rolled out an unprecedented,collaboration to ... at the Omni Hotel at CNN Center.,Through Komen for the Cure,s Circle of ...
... may explain how the two sexes evolved , FRIDAY, Jan. 11 ... seems to contain clues to gender development in humans. , Duke ... issue of Nature . , In research with Phycomyces ... that regulates mating. They named these versions sexM (sex minus) and ...
Cached Medicine News:Health News:University of Detroit Mercy School of Dentistry Moves to Larger Facility on New Corktown Campus 2Health News:University of Detroit Mercy School of Dentistry Moves to Larger Facility on New Corktown Campus 3Health News:NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14) 2Health News:NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14) 3Health News:NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14) 4Health News:NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14) 5Health News:First in Nation: notMYkid Educational Center Is Now a Reality Thanks to a Partnership Between Chrysler, Barrett-Jackson and notMYkid 2Health News:Health Groups Release 2008 Immunization Schedules 2Health News:Susan G. Komen for the Cure's Circle of Promise and The Links, Incorporated Unite to Rewrite the Story on African Americans and Breast Cancer 2Health News:Susan G. Komen for the Cure's Circle of Promise and The Links, Incorporated Unite to Rewrite the Story on African Americans and Breast Cancer 3Health News:Susan G. Komen for the Cure's Circle of Promise and The Links, Incorporated Unite to Rewrite the Story on African Americans and Breast Cancer 4Health News:Fungus Sheds Light on Development of Human Genders 2
PT-HS with Calcium - 2 ml...
... delivers performance, value and safety ... smaller laboratories. It's an affordable, ... small sample volume in both ... a wide operating range and ...
Provides the security of braided polyester suture and ease of an automated knot for vascular closure of 5-8Fr....
... For physicians looking for ... want advanced communications with electronic ... combines the best of both ... compact, easy-to-use features of the ...
Medicine Products: